Comparison of Switching to Direct Oral Anticoagulants and Continuous Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism in Taiwan

被引：0
|
作者：
Kang, Wei [1 ]
Shen, Chin-Yao [2 ]
Cheng, Michael Chun-Yuan [3 ]
Yan, Vincent Kc [4 ]
Wei, Yue [5 ]
Li, Tung Hiu [6 ]
Huang, Caige [5 ]
Lai, Edward Chia-Cheng [7 ]
Wong, Ian Chi Kei [4 ]
Chan, Esther W. [4 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[4] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[5] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[6] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
[7] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
220
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
    Kang, Wei
    Huang, Caige
    Yan, Vincent K. C.
    Wei, Yue
    Shami, Jessica J. P.
    Li, Silvia T. H.
    Yang, Yu
    Ye, Xuxiao
    Tang, Junhan
    Lee, Shing Fung
    Lee, Victor H. F.
    Chan, Stephen L.
    El Helali, Aya
    Lam, Ka On
    Ngan, Roger K. C.
    Wong, Ian C. K.
    Chan, Esther W.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [2] Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats
    O'Connell, Casey
    Escalante, Carmen P.
    Goldhaber, Samuel Z.
    McBane, Robert
    Connors, Jean M.
    Raskob, Gary E.
    ONCOLOGIST, 2021, 26 (01): : E8 - E16
  • [3] Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
    Recio-Boiles, Alejandro
    Veeravelli, Sumana
    Vondrak, Jessica
    Babiker, Hani M.
    Scott, Aaron J.
    Shroff, Rachna T.
    Patel, Hitendra
    Elquza, Emad
    McBride, Ali
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 866 - 876
  • [4] Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
    Alejandro Recio-Boiles
    Sumana Veeravelli
    Jessica Vondrak
    Hani M Babiker
    Aaron J Scott
    Rachna T Shroff
    Hitendra Patel
    Emad Elquza
    Ali McBride
    World Journal of Gastrointestinal Oncology, 2019, 11 (10) : 866 - 876
  • [5] Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism
    Coleman, Craig, I
    Caroti, Kimberly Snow
    Abdelgawwad, Khaled
    Psaroudakis, George
    Rivera, Marcela
    Brobert, Gunnar
    Cohen, Alexander T.
    Khorana, Alok A.
    Becattini, Cecilia
    Lee, Agnes Y.
    Ekbom, Anders
    Carrier, Marc
    BLOOD, 2022, 140 : 11368 - 11369
  • [6] Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
    Yhim, Ho-Young
    Bang, Soo-Mee
    BLOOD RESEARCH, 2014, 49 (02) : 77 - 79
  • [7] Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism
    Chen, Dong-Yi
    Tseng, Chi-Nan
    Hsieh, Ming-Jer
    Lan, Wen-Ching
    Chuang, Cheng-Keng
    Pang, See-Tong
    Chen, Shao-Wei
    Chen, Tien-Hsing
    Chang, Shang-Hung
    Hsieh, I-Chang
    Chu, Pao-Hsien
    Wen, Ming-Shien
    Chen, Jen-Shi
    Chang, John Wen-Cheng
    See, Lai-Chu
    Huang, Wen-Kuan
    JAMA NETWORK OPEN, 2021, 4 (02)
  • [8] Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism
    Park, Deborah Y.
    Poudel, Shyam K.
    Jia, Xuefei
    Wilks, Mailey Lynn
    Pinkava, Vicki
    O'Brien, Meghan
    Tripp, Barbara
    Song, Jung-Min
    McCrae, Keith R.
    Angelini, Dana E.
    Khorana, Alok A.
    BLOOD, 2018, 132
  • [9] Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China
    Wu, Yue
    Yin, TianChen
    Jian, Guilin
    Wan, Tao
    Zhou, BenHong
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis
    Patel, Tirath
    Nadeem, Taha
    Shahbaz, Usman
    Tanveer, Fatima
    Ahsan, Muneeb
    Saeed, Usman
    Ahmed, Abdullah
    Kumar, Vinesh
    Jaffari, Syed M. Ibne Ali
    Zaman, Mohammad U.
    Kumar, Satesh
    Khatri, Mahima
    Varrassi, Giustino
    Vanga, Prasanthi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
12345